Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
The Monthly: January 2025
10th Jan 2025
Real Estate Credit Investments (RECI)
January 2025 Monthly
10th Jan 2025
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
109: Where are we in the venture capital cycle? | Henry Whorwood of Beauhurst
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
The Monthly: January 2019
11 Jan 2019
Burford Capital
Financials
Next $1.6bn of investments to boost returns
By
Dr Brian Moretta
03 Jan 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Titon Holdings
Building & Construction
Good moon rising
18 Dec 2018
Tissue Regenix
Life Sciences
2018 in review: foundations laid for osteobiologics
17 Dec 2018
DP Poland Plc
Consumer
Slowing revenue growth
By
Jason Streets
12 Dec 2018
genedrive Plc
Life Sciences
Accelerating into fiscal 2019 with first sales
10 Dec 2018
Avacta Group plc
Life Sciences
Wake-up call for the market
10 Dec 2018
Gateley Plc
Services
Strong trading and industry opportunity
By
Steve Clapham
07 Dec 2018
Non-Standard Finance
Financials
Reading the runes: strong, controlled growth
By
Mark Thomas
05 Dec 2018
Redx Pharma
Life Sciences
RXC006: first anti-fibrosis development candidate
By
Dr Martin Hall
30 Nov 2018
Palace Capital
Property
Interim results to September 2018 reported
By
Mike Foster
28 Nov 2018
Prev
1
...
56
57
58
59
60
...
78
Next
